148 related articles for article (PubMed ID: 23804268)
21. Targeting CLEC9A delivers antigen to human CD141
Tullett KM; Leal Rojas IM; Minoda Y; Tan PS; Zhang JG; Smith C; Khanna R; Shortman K; Caminschi I; Lahoud MH; Radford KJ
JCI Insight; 2016 May; 1(7):e87102. PubMed ID: 27699265
[TBL] [Abstract][Full Text] [Related]
22. Advancing drug delivery systems for the treatment of multiple sclerosis.
Tabansky I; Messina MD; Bangeranye C; Goldstein J; Blitz-Shabbir KM; Machado S; Jeganathan V; Wright P; Najjar S; Cao Y; Sands W; Keskin DB; Stern JN
Immunol Res; 2015 Dec; 63(1-3):58-69. PubMed ID: 26475738
[TBL] [Abstract][Full Text] [Related]
23. Regulatory dendritic cells for immunotherapy in immunologic diseases.
Gordon JR; Ma Y; Churchman L; Gordon SA; Dawicki W
Front Immunol; 2014; 5():7. PubMed ID: 24550907
[TBL] [Abstract][Full Text] [Related]
24. Tolerogenic dendritic cells.
Steinman RM; Hawiger D; Nussenzweig MC
Annu Rev Immunol; 2003; 21():685-711. PubMed ID: 12615891
[TBL] [Abstract][Full Text] [Related]
25. Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells.
Yamazaki S; Steinman RM
J Dermatol Sci; 2009 May; 54(2):69-75. PubMed ID: 19286352
[TBL] [Abstract][Full Text] [Related]
26. Targeted antigen delivery to DEC-205⁺ dendritic cells for tolerogenic vaccination.
Petzold C; Schallenberg S; Stern JN; Kretschmer K
Rev Diabet Stud; 2012; 9(4):305-18. PubMed ID: 23804268
[TBL] [Abstract][Full Text] [Related]
27. Targeting DEC-205
Tabansky I; Keskin DB; Watts D; Petzold C; Funaro M; Sands W; Wright P; Yunis EJ; Najjar S; Diamond B; Cao Y; Mooney D; Kretschmer K; Stern JNH
Mol Med; 2018 May; 24(1):17. PubMed ID: 30134798
[TBL] [Abstract][Full Text] [Related]
28. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice.
Mukhopadhaya A; Hanafusa T; Jarchum I; Chen YG; Iwai Y; Serreze DV; Steinman RM; Tarbell KV; DiLorenzo TP
Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6374-9. PubMed ID: 18430797
[TBL] [Abstract][Full Text] [Related]
29. DCIR2+ cDC2 DCs and Zbtb32 Restore CD4+ T-Cell Tolerance and Inhibit Diabetes.
Price JD; Hotta-Iwamura C; Zhao Y; Beauchamp NM; Tarbell KV
Diabetes; 2015 Oct; 64(10):3521-31. PubMed ID: 26070317
[TBL] [Abstract][Full Text] [Related]
30. Modification of anti-tumor immunity by tolerogenic dendritic cells.
Chen L; Hasni MS; Jondal M; Yakimchuk K
Autoimmunity; 2017 Sep; 50(6):370-376. PubMed ID: 28675711
[TBL] [Abstract][Full Text] [Related]
31. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation.
Birkholz K; Schwenkert M; Kellner C; Gross S; Fey G; Schuler-Thurner B; Schuler G; Schaft N; Dörrie J
Blood; 2010 Sep; 116(13):2277-85. PubMed ID: 20566893
[TBL] [Abstract][Full Text] [Related]
32. Foxp3(+) regulatory T cells in mouse models of type 1 diabetes.
Petzold C; Riewaldt J; Watts D; Sparwasser T; Schallenberg S; Kretschmer K
J Diabetes Res; 2013; 2013():940710. PubMed ID: 23691523
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy in autoimmune type 1 diabetes.
Weigmann B; Franke RK; Daniel C
Rev Diabet Stud; 2012; 9(2-3):68-81. PubMed ID: 23403703
[TBL] [Abstract][Full Text] [Related]
34. Specialized role of migratory dendritic cells in peripheral tolerance induction.
Idoyaga J; Fiorese C; Zbytnuik L; Lubkin A; Miller J; Malissen B; Mucida D; Merad M; Steinman RM
J Clin Invest; 2013 Feb; 123(2):844-54. PubMed ID: 23298832
[TBL] [Abstract][Full Text] [Related]
35. Targeting viral antigens to CD11c on dendritic cells induces retrovirus-specific T cell responses.
Ejaz A; Ammann CG; Werner R; Huber G; Oberhauser V; Hörl S; Schimmer S; Dittmer U; von Laer D; Stoiber H; Bánki Z
PLoS One; 2012; 7(9):e45102. PubMed ID: 23028784
[TBL] [Abstract][Full Text] [Related]
36. Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.
Wang B; Zaidi N; He LZ; Zhang L; Kuroiwa JM; Keler T; Steinman RM
Breast Cancer Res; 2012 Mar; 14(2):R39. PubMed ID: 22397502
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
